PTBP1 and pituitary gland adenoma: Through a comprehensive analysis of the results of histological and cytological experiments, we found that the expression of SLC27A1 was significantly high in aggressive pituitary adenomas and TMZ therapy sensitive cell lines, while the expression of PTBP1 and EIF5A was significantly decreased.